{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:09:43Z","timestamp":1785168583414,"version":"3.55.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1093\/ndt\/gfi212","type":"journal-article","created":{"date-parts":[[2005,10,26]],"date-time":"2005-10-26T08:53:42Z","timestamp":1130316822000},"page":"478-482","source":"Crossref","is-referenced-by-count":126,"title":["The course of type 1 hepato-renal syndrome post liver transplantation"],"prefix":"10.1093","volume":"21","author":[{"given":"Paul E.","family":"Marik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Starzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,25]]},"reference":[{"key":"key\n\t\t\t\t20171012182529_BIB1","doi-asserted-by":"crossref","unstructured":"Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS. Impact of pretransplant renal function on survival after liver transplantation. Transplantation1995; 59: 361\u2013365","DOI":"10.1097\/00007890-199502150-00010"},{"key":"key\n\t\t\t\t20171012182529_BIB2","unstructured":"Lafayette RA, Pare G, Schmid CH, King AJ, Rohrer RJ, Nasraway SA. Pretransplant renal dysfunction predicts poorer outcome in liver transplantation. Clin Nephrol1997; 48: 159\u2013164"},{"key":"key\n\t\t\t\t20171012182529_BIB3","doi-asserted-by":"crossref","unstructured":"Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet2003; 362: 1819\u20131827","DOI":"10.1016\/S0140-6736(03)14903-3"},{"key":"key\n\t\t\t\t20171012182529_BIB4","doi-asserted-by":"crossref","unstructured":"Gines A, Escorsell A, Gines P et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology1993; 105: 229\u2013236","DOI":"10.1016\/0016-5085(93)90031-7"},{"key":"key\n\t\t\t\t20171012182529_BIB5","doi-asserted-by":"crossref","unstructured":"Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology1988; 8: 1151\u20131157","DOI":"10.1002\/hep.1840080532"},{"key":"key\n\t\t\t\t20171012182529_BIB6","doi-asserted-by":"crossref","unstructured":"Cassinello C, Moreno E, Gozalo A, Ortuno B, Cuenca B, Solis-Herruzo JA. Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci2003; 48: 179\u2013186","DOI":"10.1023\/A:1021763221337"},{"key":"key\n\t\t\t\t20171012182529_BIB7","doi-asserted-by":"crossref","unstructured":"Arroyo V, Gines P, Gerbes AL et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology1996; 23: 164\u2013176","DOI":"10.1002\/hep.510230122"},{"key":"key\n\t\t\t\t20171012182529_BIB8","doi-asserted-by":"crossref","unstructured":"Moreau R. Hepatorenal syndrome in patients with cirrhosis. J Gastroenterol Hepatol2002; 17: 739\u2013747","DOI":"10.1046\/j.1440-1746.2002.02778.x"},{"key":"key\n\t\t\t\t20171012182529_BIB9","doi-asserted-by":"crossref","unstructured":"Watt K, Uhanova J, Minuk GY. Hepatorenal syndrome: diagnostic accuracy, clinical features and outcome in a tertiary care center. Am J Gastroenterol2002; 97: 2046\u20132050","DOI":"10.1111\/j.1572-0241.2002.05920.x"},{"key":"key\n\t\t\t\t20171012182529_BIB10","doi-asserted-by":"crossref","unstructured":"Angeli P. Review article: prognosis of hepatorenal syndrome \u2013 has it changed with current practice? Alimentary Pharmacology & Therapeutics2004; 20 [Suppl 3]: 44\u201346","DOI":"10.1111\/j.1365-2036.2004.02113.x"},{"key":"key\n\t\t\t\t20171012182529_BIB11","doi-asserted-by":"crossref","unstructured":"Cardenas A, Arroyo V. Hepatorenal syndrome. Ann Hepatol2003; 2: 23\u201329","DOI":"10.1016\/S1665-2681(19)32154-4"},{"key":"key\n\t\t\t\t20171012182529_BIB12","doi-asserted-by":"crossref","unstructured":"Saner FH, Fruhauf NR, Schafers RF, Lang H, Malago M, Broelsch CE. Terlipressin plus hydroxyethyl starch infusion: an effective treatment for hepatorenal syndrome. Eur J Gastroenterol Hepatol2003; 15: 925\u2013927","DOI":"10.1097\/00042737-200308000-00015"},{"key":"key\n\t\t\t\t20171012182529_BIB13","doi-asserted-by":"crossref","unstructured":"Duvoux C, Zanditenas D, Hezode C et al. Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study. Hepatology2002; 36: 374\u2013380","DOI":"10.1053\/jhep.2002.34343"},{"key":"key\n\t\t\t\t20171012182529_BIB14","doi-asserted-by":"crossref","unstructured":"Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol2003; 18: 152\u2013156","DOI":"10.1046\/j.1440-1746.2003.02934.x"},{"key":"key\n\t\t\t\t20171012182529_BIB15","doi-asserted-by":"crossref","unstructured":"Moreau R, Durand F, Poynard T et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology2002; 122: 923\u2013930","DOI":"10.1053\/gast.2002.32364"},{"key":"key\n\t\t\t\t20171012182529_BIB16","doi-asserted-by":"crossref","unstructured":"Catalano G, Urbani L, Biancofiore G et al. Selection and preparation of candidates for combined liver-kidney transplantation: experience at a single center-two case reports. Transplantat Proc2004; 36: 539\u2013540","DOI":"10.1016\/j.transproceed.2004.02.030"},{"key":"key\n\t\t\t\t20171012182529_BIB17","doi-asserted-by":"crossref","unstructured":"Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology2003; 124: 91\u201396","DOI":"10.1053\/gast.2003.50016"},{"key":"key\n\t\t\t\t20171012182529_BIB18","doi-asserted-by":"crossref","unstructured":"Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med1992; 20: 864\u2013874","DOI":"10.1097\/00003246-199206000-00025"},{"key":"key\n\t\t\t\t20171012182529_BIB19","doi-asserted-by":"crossref","unstructured":"Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB. Long-term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome\u2013experience in 300 patients. Transplantation1991; 51: 428\u2013430","DOI":"10.1097\/00007890-199102000-00030"},{"key":"key\n\t\t\t\t20171012182529_BIB20","doi-asserted-by":"crossref","unstructured":"Iwatsuki S, Popovtzer MM, Corman JL et al. Recovery from \u201chepatorenal syndrome\u201d after orthotopic liver transplantation. N Engl J Med1973; 289: 1155\u20131159","DOI":"10.1056\/NEJM197311292892201"},{"key":"key\n\t\t\t\t20171012182529_BIB21","doi-asserted-by":"crossref","unstructured":"Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Renal Failure2004; 26: 563\u2013568","DOI":"10.1081\/JDI-200035988"},{"key":"key\n\t\t\t\t20171012182529_BIB22","doi-asserted-by":"crossref","unstructured":"Rasaratnam B, Kaye D, Jennings G, Dudley F, Chin-Dusting J. The effect of selective intestinal decontamination on the hyperdynamic circulatory state in cirrhosis. A randomized trial. Ann Intern Med2003; 139: 186\u2013193","DOI":"10.7326\/0003-4819-139-3-200308050-00008"},{"key":"key\n\t\t\t\t20171012182529_BIB23","doi-asserted-by":"crossref","unstructured":"Mookerjee RP, Sen S, Davies NA, Hodges SJ, Williams R, Jalan R. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis. Gut2003; 52: 1182\u20131187","DOI":"10.1136\/gut.52.8.1182"},{"key":"key\n\t\t\t\t20171012182529_BIB24","doi-asserted-by":"crossref","unstructured":"Iglesias J, Marik PE, Levine JS, Norasept IS, I. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis2003; 41: 62\u201375","DOI":"10.1053\/ajkd.2003.50024"},{"key":"key\n\t\t\t\t20171012182529_BIB25","doi-asserted-by":"crossref","unstructured":"Anggard E, Jones AW, Neri A. Effect of acute and chronic ethanol treatment on renal prostaglandins in the rat. Alcohol1985; 2: 647\u2013650","DOI":"10.1016\/0741-8329(85)90140-5"},{"key":"key\n\t\t\t\t20171012182529_BIB26","unstructured":"Vamvakas S, Teschner M, Bahner U, Heidland A. Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin Nephrol1998; 49: 205\u2013213"},{"key":"key\n\t\t\t\t20171012182529_BIB27","doi-asserted-by":"crossref","unstructured":"Van Thiel DH, Gavaler JS, Little JM, Lester R. Alcohol: its effect on the kidney. Adv Exp Med Biol1977; 85A: 449\u2013457","DOI":"10.1007\/978-1-4899-5181-6_27"},{"key":"key\n\t\t\t\t20171012182529_BIB28","unstructured":"Van Thiel DH, Williams WD Jr., Gavaler JS, Little JM, Estes LW, Rabin BS. Ethanol\u2013its nephrotoxic effect in the rat. Am J Pathol1977; 89: 67\u201383"},{"key":"key\n\t\t\t\t20171012182529_BIB29","doi-asserted-by":"crossref","unstructured":"Jeyarajah DR, Gonwa TA, McBride M et al. Hepatorenal syndrome: combined liver kidney transplants versus isolated liver transplant. Transplantation1997; 64: 1760\u20131765","DOI":"10.1097\/00007890-199712270-00024"},{"key":"key\n\t\t\t\t20171012182529_BIB30","doi-asserted-by":"crossref","unstructured":"Margreiter R, Konigsrainer A, Spechtenhauser B et al. Our experience with combined liver-kidney transplantation: an update. Transplant Proc2002; 34: 2491\u20132492","DOI":"10.1016\/S0041-1345(02)03187-1"},{"key":"key\n\t\t\t\t20171012182529_BIB31","doi-asserted-by":"crossref","unstructured":"Jeyarajah DR, McBride M, Klintmalm GB, Gonwa TA. Combined liver-kidney transplantation: what are the indications? Transplantation1997; 64: 1091\u20131096","DOI":"10.1097\/00007890-199710270-00001"},{"key":"key\n\t\t\t\t20171012182529_BIB32","doi-asserted-by":"crossref","unstructured":"Restuccia T, Ortega R, Guevara M et al. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study. J Hepatol2004; 40: 140\u2013146","DOI":"10.1016\/j.jhep.2003.09.019"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/21\/2\/478\/5235148\/gfi212.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T13:52:15Z","timestamp":1586526735000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/ndt\/article\/21\/2\/478\/1850728\/The-course-of-type-1-hepatorenal-syndrome-post"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,25]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2005,10,25]]},"published-print":{"date-parts":[[2006,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfi212","relation":{},"ISSN":["1460-2385","0931-0509"],"issn-type":[{"value":"1460-2385","type":"electronic"},{"value":"0931-0509","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,2]]},"published":{"date-parts":[[2005,10,25]]}}}